stocks
GSKCONS

GlaxoSmithKline Consumer Healthcare Ltd

Sector:
Industry Group:
Industry:
10,732.60+0.0 (+0.00%)
20 Aug, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
-
P/E (TTM)
-
P/B
-
P/S (TTM)
-
EV/EBITDA
-
CAPE (5Y)
54.29
ROE (TTM)
-
ROCE (TTM)
-
ROA (TTM)
-
Avg 3Y ROE
-
Earnings 3Y CAGR
-
Sales 3Y CAGR
-
Sales 5Y CAGR
-
Debt/Equity
-
Consensus TP
-
Strong Buy %
-
Promoter Holding
-
Pledged %
-

Share Price

Track GlaxoSmithKline Consumer Healthcare Ltd's current share price, historical price chart, 52-week high/low, and performance across different time periods.

Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for GlaxoSmithKline Consumer Healthcare Ltd covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

GlaxoSmithKline Consumer Healthcare Ltd Shareholding Pattern

Quarterly breakdown of GlaxoSmithKline Consumer Healthcare Ltd ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in GlaxoSmithKline Consumer Healthcare Ltd shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of GlaxoSmithKline Consumer Healthcare Ltd?
The current share price of GlaxoSmithKline Consumer Healthcare Ltd is ₹ 10,732.60 as of 20 Aug 2020.
What is the market capitalisation of GlaxoSmithKline Consumer Healthcare Ltd?
The market capitalisation of GlaxoSmithKline Consumer Healthcare Ltd stands at -.
What is the PE ratio of GlaxoSmithKline Consumer Healthcare Ltd?
The Price-to-Earnings (PE) ratio of GlaxoSmithKline Consumer Healthcare Ltd is - as of the latest trailing twelve months data.
What is the ROE and ROCE of GlaxoSmithKline Consumer Healthcare Ltd?
GlaxoSmithKline Consumer Healthcare Ltd has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.
What is the 52-week high and low of GlaxoSmithKline Consumer Healthcare Ltd?
The 52-week high of GlaxoSmithKline Consumer Healthcare Ltd is - and the 52-week low is -.
What is the dividend yield of GlaxoSmithKline Consumer Healthcare Ltd?
The dividend yield of GlaxoSmithKline Consumer Healthcare Ltd is 0.98% based on the current market price.
What is the FII and DII holding in GlaxoSmithKline Consumer Healthcare Ltd?
Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of GlaxoSmithKline Consumer Healthcare Ltd shares.
What sector does GlaxoSmithKline Consumer Healthcare Ltd belong to?
GlaxoSmithKline Consumer Healthcare Ltd operates in the - sector.
What is the beta of GlaxoSmithKline Consumer Healthcare Ltd?
The beta of GlaxoSmithKline Consumer Healthcare Ltd is 0.57, indicating its price volatility relative to the broader market. Over the past 1 year, GlaxoSmithKline Consumer Healthcare Ltd has delivered an absolute return of 34.71%.
What is the RSI of GlaxoSmithKline Consumer Healthcare Ltd?
The 14-day Relative Strength Index (RSI) of GlaxoSmithKline Consumer Healthcare Ltd is 62.66, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.